• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number LIFEVEST WCD 4000 SYSTEM
Device Problem Signal Artifact/Noise (1036)
Patient Problems Arrhythmia (1721); Bradycardia (1751); Asystole (4442)
Event Date 11/03/2022
Event Type  Death  
Manufacturer Narrative
The electrode belt and monitor have been returned and the evaluation is underway.The device flag data from the last download does not indicate any device malfunction.
 
Event Description
A us distributor contacted zoll to report that a patient passed away on (b)(6) 2022 while reportedly wearing the lifevest.The patient four appropriate treatments, three of which converted the arrhythmias to a slower rhythm and one which resulted in post shock asystole.The device was started up at 07:31:46 on (b)(6) 2022.At 20:06:45, an arrhythmia was detected.Ecg shows sinus rhythm @ 80 bpm degrading to vf.At 20:07:21, the patient received the first appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was asystole with motion artifact for 26 seconds transitioning to sinus bradycardia @ 20 bpm.Post-shock asystole is a known and potentially adverse outcome of defibrillation therapy.At 20:08:47, an arrhythmia was detected.Ecg shows vf.At 20:09:17, the patient received the second appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 30 bpm.At 20:09:53, an arrhythmia was detected.Ecg shows vf.At 20:10:29, the patient received the third appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 30 bpm.At 20:11:15, an arrhythmia was detected.Ecg shows vf.At 20:11:51, the patient received the fourth appropriate treatment.The rhythm at the time of treatment was vf.The post shock rhythm was sinus bradycardia @ 40 bpm.The device was shut down at 1:08:57 on (b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA
Manufacturer Contact
zoll mfg corporation
121 gamma drive
pittsburgh, PA 15238
MDR Report Key16059866
MDR Text Key306245365
Report Number3008642652-2022-26983
Device Sequence Number1
Product Code MVK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 12/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberLIFEVEST WCD 4000 SYSTEM
Date Manufacturer Received11/29/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-